Understanding MMR0 in a measles outbreak - webinar recording

‍

IMAC has hosted a webinar on the role of MMR0 (the early MMR dose for infants aged 4–11 months) as a targeted tool during measles outbreaks.

This session clarifies when and why MMR0 is implemented, and how it fits within broader efforts to achieve the 95% herd immunity needed to prevent sustained measles transmission.

It covers the latest clinical guidance and practical issues, including communicating with whānau the benefits of MMR0 in an outbreak setting; vaccine safety; how to achieve equitable delivery; and more.

View the webinar here